跳至主要内容
临床试验/KCT0005052
KCT0005052尚未招募未知

The efficacy and safety of observation therapy or terazosin 2mg or 5mg administration for Distal Ureter Stone patients

Seoul Medical Center0 个研究点目标入组 194 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
194

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) Men over 19
  • 2) Those with lower urinary tract stones less than 10mm in diameter
  • 3) A person who voluntarily decides to participate in this study and agrees in writing to the subject consent

排除标准

  • 1) People with urinary tract infection
  • 2) A person with a severe hydronephrosis
  • 3) Those who have multiple stones
  • 4) Patients with ureteral stenosis
  • 5) Patients who are currently taking Calcium Channel Blocker or Alpha Blocker
  • 6) Those who are sensitive to alpha-blocker preparations
  • 7) Patients with Systolic blood pressure <110mmHg
  • 8) Patients who has a history of surgery related to the urinary tract
  • 9) Others who are inappropriate to participate in research as judged by the Primary Investigator or other Investigators

研究者

相似试验